Healthcare provider profile · identity verified

Lynnae Edwards, M.D

Internal Medicine · MORROW, GA · NPI 1902302144

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	491	151
Amlodipine Besylate	Amlodipine Besylate	390	125
Diclofenac Sodium	Diclofenac Sodium	339	198
Albuterol Sulfate Hfa	Albuterol Sulfate	313	121
Pantoprazole Sodium	Pantoprazole Sodium	230	83
Rosuvastatin Calcium	Rosuvastatin Calcium	209	64
Furosemide	Furosemide	206	75
Gabapentin	Gabapentin	204	101
Fluticasone Propionate	Fluticasone Propionate	198	106
Losartan Potassium	Losartan Potassium	192	63
Carvedilol	Carvedilol	167	58
Hydrochlorothiazide	Hydrochlorothiazide	166	56
Metformin Hcl	Metformin Hcl	157	47
Prednisone	Prednisone	151	75
Duloxetine Hcl	Duloxetine Hcl	140	51
Tizanidine Hcl	Tizanidine Hcl	140	63
Lisinopril	Lisinopril	138	42
Metformin Hcl Er	Metformin Hcl	131	44
Ozempic	Semaglutide	121	22
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	117	41
Levothyroxine Sodium	Levothyroxine Sodium	115	35
Potassium Chloride	Potassium Chloride	115	37
Omeprazole	Omeprazole	114	48
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	106	32
Naproxen	Naproxen	103	65
Metoprolol Succinate	Metoprolol Succinate	100	35
Trazodone Hcl	Trazodone Hcl	100	31
Nifedipine Er	Nifedipine	96	33
Tramadol Hcl	Tramadol Hcl	85	35
Ibuprofen	Ibuprofen	84	51
Montelukast Sodium	Montelukast Sodium	84	26
Triamcinolone Acetonide	Triamcinolone Acetonide	81	49
Eliquis	Apixaban	80	21
Simvastatin	Simvastatin	80	27
Tamsulosin Hcl	Tamsulosin Hcl	76	32
Citalopram Hbr	Citalopram Hydrobromide	74	30
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	70	30
Glipizide	Glipizide	68	22
Azithromycin	Azithromycin	66	51
Famotidine	Famotidine	61	23
Clopidogrel	Clopidogrel Bisulfate	60	23
Baclofen	Baclofen	58	20
Hydralazine Hcl	Hydralazine Hcl	58	20
Metoprolol Tartrate	Metoprolol Tartrate	58	21
Meclizine Hcl	Meclizine Hcl	56	33
Donepezil Hcl	Donepezil Hcl	52	21
Warfarin Sodium	Warfarin Sodium	52	12
Meloxicam	Meloxicam	50	26
Quetiapine Fumarate	Quetiapine Fumarate	50	suppressed
Alendronate Sodium	Alendronate Sodium	49	20
Allopurinol	Allopurinol	47	14
Sertraline Hcl	Sertraline Hcl	47	16
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	46	15
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	44	43
Pregabalin	Pregabalin	41	suppressed
Pravastatin Sodium	Pravastatin Sodium	40	15
Ondansetron Odt	Ondansetron	39	24
Alprazolam	Alprazolam	37	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	35	12
Januvia	Sitagliptin Phosphate	34	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	32	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	32	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	31	suppressed
Ezetimibe	Ezetimibe	31	suppressed
Fluconazole	Fluconazole	31	18
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	31	suppressed
Jardiance	Empagliflozin	30	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	30	suppressed
Hydrocortisone	Hydrocortisone	29	16
Lorazepam	Lorazepam	29	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	28	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	27	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	27	suppressed
Trulicity	Dulaglutide	27	suppressed
Lactulose	Lactulose	26	14
Memantine Hcl	Memantine Hcl	25	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	25	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	24	11
Topiramate	Topiramate	24	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	24	suppressed
Finasteride	Finasteride	23	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Atenolol	Atenolol	22	suppressed
Farxiga	Dapagliflozin Propanediol	22	suppressed
Mupirocin	Mupirocin	22	17
Ciclopirox	Ciclopirox	21	16
Ibu	Ibuprofen	21	suppressed
Acyclovir	Acyclovir	20	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	20	suppressed
Latanoprost	Latanoprost	20	suppressed
Levetiracetam	Levetiracetam	20	suppressed
Mirtazapine	Mirtazapine	20	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Cephalexin	Cephalexin	17	14
Chlorthalidone	Chlorthalidone	17	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	17	suppressed
Glimepiride	Glimepiride	17	suppressed
Ketoconazole	Ketoconazole	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	17
Paxlovid	Nirmatrelvir/Ritonavir	17	17
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Lidocaine	Lidocaine	16	suppressed
Sildenafil Citrate	Sildenafil Citrate	15	suppressed
Valsartan	Valsartan	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Novolog Flexpen	Insulin Aspart	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Oxycodone Hcl	Oxycodone Hcl	14	suppressed
Ammonium Lactate	Ammonium Lactate	13	suppressed
Clobetasol Propionate	Clobetasol Propionate	13	11
Primidone	Primidone	13	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Nitroglycerin	Nitroglycerin	12	12
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Spironolactone	Spironolactone	12	suppressed
Torsemide	Torsemide	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Loperamide	Loperamide Hcl	11	suppressed
Megestrol Acetate	Megestrol Acetate	11	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error